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Abstract: Escherichia coli is an extensively used host for the production of recombinant proteins, making its N-terminal methionine
aminopeptidase (MAP) an attractive candidate for studies on posttranslational protein processing. The present study describes the
recombinant production and properties of MAP from the DH5α strain of E. coli. The soluble and active enzyme was produced in E.
coli BL21 (DE3) RIL - codon plus cells under a T7 promoter system and purified by anion-exchange chromatography. It exhibited a
molecular weight of 29,200.94 Da by MALDI-TOF analysis. The purified enzyme showed specific activity of 1.64 U/mg with methionylp-nitroanilide and 1.51 U/mg with synthetic tetrapeptide substrate ‘MGMM’ in a discontinuous HPLC-based assay. In vitro studies
showed the processing of up to 36% of Met-INFα-2b in 40 min. In silico studies revealed that the ES-complex formation between the
enzyme and interferon has a ΔG –683.07 kJ/mol. Molecular docking results showed that the processed INFα-2b has greater binding
affinity with IFNAR2 receptor as indicated by ΔG –784.53 kJ/mol, significantly lower than that of methionine containing INFα-2b
(ΔG –717.63 kJ/mol). These findings emphasize the functional superiority or better efficacy of N-terminal methionine processed
recombinant interferon.
Key words: Methionine aminopeptidase, E. coli, human interferon, in vitro, in silico

1. Introduction
The production of recombinant proteins and their
therapeutic applications have brought a revolution in
biomedical sciences. Recombinants of many proteins
including lymphokines, interferons and interleukins
(Rider et al., 2016; Shepelkova et al., 2016; Lagasse et al.,
2017), enzymes (Seal, 2013; Vairo et al., 2013; Dolores and
Ortiz, 2016), and hormones like insulin and human growth
hormone (Urbano et al., 2012; Miljic et al., 2013) have been
used in recent times. In the E. coli expression system, a
proportion of recombinant proteins retain an unprocessed
methionine at the N-terminus, which is contrary to their
native forms. Attempts have been made to make replicas
of native proteins for therapeutic applications (Goh et
al., 2017; Wingfield, 2017). Methionine aminopeptidase
(MAP) is a metalloprotease that catalyzes the hydrolytic
removal of N-terminal methionine of an elongating
polypeptide chain during the process of protein synthesis
(Giglione et al., 2004; Arif et al., 2015). The hydrolysis
of N-terminal methionine is mandatory in 50%–70% of
nascent proteins (Bingel-Erlenmeyer et al., 2008; Kanodia
et al., 2011) and usually occurs only when the penultimate
* Correspondence: mhalim@kau.edu.sa
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amino acid, which is adjacent to the initiator methionine,
has a radius of gyration of 1.29 Å or less. These amino
acids are glycine, alanine, proline, serine, cysteine,
threonine, and valine (Xiao et al., 2010). The methionine
aminopeptidases belonging to different origins have
similar active sites and mechanism of action but differ in
individual active site residues, which may possibly alter
the behavior of the enzyme towards different substrates
and inhibitors (Lowther et al., 1999; Helgren et al., 2016).
Recombinant therapeutic proteins are converted to their
native form by removal of N-terminal methionine residue
(Arif et al., 2015; Calcagno and Klein, 2016). Because of
its easy manipulation, cultivation, high yield, and better
economy, the E. coli strains include the most extensively
used protein expression systems (Elleuche et al., 2015;
Cantu-Bustos et al, 2016; Chen et al., 2016; Jia and Jeon,
2016). Once produced in E. coli, activity of aminopeptidase
is one of many decisive factors for a recombinant protein
to exhibit a replica of its native form (Tripathi, 2016).
In silico 3-D structure determination and molecular
docking techniques are increasingly used tools and
techniques to study the binding specificity of hormones
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and substrates against their corresponding receptors and
enzymes (Venkatachalam et al., 2003). During the last
two decades, about 60 docking software programs and
tools have been developed for commercial and academic
applications (Allen et al., 2015; Yang and Zhang, 2015).
The present study describes the recombinant production,
purification, and biochemical properties of E. coli
N-terminal methionine aminopeptidase, and application
of enzyme in the processing of recombinant interferon. We
have also applied in silico tools to evaluate the interaction
of met-INF with E. coli MAP, binding free energy changes
of met-INF, and nonmet-INF molecules with the interferon
receptors.
2. Materials and methods
2.1. Preparation of recombinant plasmid
The E. coli (DH5α) methionine aminopeptidase
gene
was
PCR
amplified,
using
primer
sequences
5’-catatggctatctcaatcaagacccc-3’
and
5’-ttattcgtcgtgcgagattatcgcc-3’ under optimized conditions
(2 mM MgCl2, 1.5 mM dNTPs, Taq buffer solution, 20 pM
of each primer, 2.5 units Taq polymerase). The complete
open reading frame encoding methionine aminopeptidase
(MAP) was ligated into pTZ57R/T (Thermo Fisher
Scientific catalogue number: K1213) by T/A cloning.
The gene consisting of 795 base pairs was restricted out
from the plasmid above by NdeI and EcoRI and ligated
into pET21a (+) expression plasmid (Novagen catalogue
number: 69770-3) using the procedure described by our
previous studies with modifications (Arif et al., 2016).
2.2. Cloning and expression of the MAP gene
The recombinant plasmid pET21-MAP (expression
plasmid ligated with gene encoding enzyme) was used for
the transformation of E. coli BL21 (DE3) - RIL codon plus
cells (Agilent Technologies catalogue number 230240).
Clones confirmed for the presence of recombinant plasmid
were used to grow the culture on a small scale; gene
expression was induced by 0.4 mM IPTG when the OD
of culture was 0.6 at 600 nm. The culture was incubated
overnight at 20 °C and expression was analyzed on 15%
SDS-PAGE (Laemmli, 1970).
2.3. Purification and molecular weight determination
The cell pellet (4.3 g) obtained from 1 L of E. coli culture
induced for protein expression was suspended in 50 mL of
50 mM phosphate buffer pH 7.5 and sonicated for 1 min
(6 pulses of 10 s at moderate power). The sonicated sample
was centrifuged at 14,000 × g for 15 min at 4 °C and the
supernatant was transferred to a sterile falcon tube followed
by filtration using a 0.45 µm pore size filter (Millipore Inc.).
The enzyme was purified by dialysis and anion-exchange
chromatography using Q-Sepharose equilibrated with 40
mM HEPES buffer pH 7.5. The sample was applied to the
column at a flow rate of 2 mL/min, unbound proteins were

washed with the equilibration buffer, and bound proteins
were eluted with a linear gradient of 0.5 M NaCl solution.
Fractions of 5 mL were collected, quantified, and analyzed
separately. The entire purification process was conducted
at 4 °C and protein was quantified by Bradford’s method
(Bradford, 1976). A desalted purified enzyme sample
(2.7 mg) was mixed with 4.5 mg of sinapinic acid in 1
mL of 30% acetonitrile containing 0.15% trifluroacetic
acid, and a small aliquot of the mixture was spotted on
a mass spectrometric plate and allowed to air dry. The
mass spectrum of the enzyme was recorded with a Bruker
Autoflex MALDI-TOF (Bruker Daltonics Inc., Billerica,
MA, USA).
2.4. Methionyl p-nitroanilide-based assay
A modified method adopted from the literature was
applied for the enzyme assay (Zhou et al., 2000).
Methionine aminopeptidase catalyzes the conversion
of methionyl p-nitroanilide to p-nitroaniline and
methionine. p-Nitroaniline absorbs light at 405 nm. To the
experimental and reference cuvette were added 1440 µL of
40 mM HEPES buffer pH 7.5, 400 µL of 1 mM KCl, 60 µL of
50 mM CoCl2, and 3 µL of substrate (100 mM methionine
p-nitroanilide in ethanol). To the experimental cuvette
was added 75 µL (97.5 µg) of enzyme and to the reference
cuvette 75 µL of buffer. The change in absorbance at 405
nm was measured over 30 min. The extinction coefficient
of absorbing species (p-nitroaniline) was considered as
9.96 mM–1 cm–1 for the calculation of enzyme activity. The
assay was performed for the determination of optimum
pH and temperature for enzyme.
2.5. HPLC-based enzyme assay using MGMM as
substrate
The assay method described by Xiao et al. (2010) was applied
with modifications to measure the enzyme activity. The
retention time and volume for the synthetic tetrapeptide
MGMM and its product glycine-methionine-methionine
GMM was determined. Solutions containing 10 µg of
MGMM and GMM were separately taken in Eppendorf
tubes, diluted to 20 µL with filtered distilled water, and
loaded on an analytical C8 chromatographic column. The
retention volume was determined with 1.0 mL/min flow
rate, 0% to 30% linear gradient of acetonitrile in 0.1% TFA
water with 1% ramp per min. The tri- and tetrapeptide
eluted at 16% and 23% of acetonitrile, respectively. The
retention time of both MGMM and GMM provided a
baseline for the enzyme assays. For the enzyme assay, 175
mM KCl, 50 mM CoCl2, 20 µL of enzyme 1.3 µg/µL, and
25 mM HEPES buffer 60 µL were taken and incubated at
30 °C for 10 min so that the reaction mixture attained the
temperature (solution A). In another Eppendorf tube, 1.9
mM substrate and 92 µL of 25 mM HEPES pH 7.5 were
added (solution B). After 10 min of enzyme incubation
with the KCl and CoCl2 solution B was added to solution A
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at 30 °C. The reaction mixture (66 µL) was removed at time
zero and added to an Eppendorf tube containing 5 µL of 10%
TFA to quench the reaction. Similarly, the reaction of 66 µL
of sample was quenched after 5 and 10 min intervals. The
samples were separately loaded on the chromatographic C8
column and profile of substrate to product was observed
under the optimized conditions. One unit was defined as
the amount of enzyme required to eliminate N-terminal
methionine from 1 µmol of tetrapeptide MGMM in 1 min.
2.6. Processing of N-terminal methionine from MetINFα-2b
The recombinant interferon alpha 2b, with N-terminal
methionine was obtained from our previous studies (Arif
et al., 2015). In an Eppendorf tube (A), 400 µL of reaction
mixture containing 175 mM KCl, 50 mM CoCl2, 200 µg of
enzyme, and 25 mM HEPES buffer pH 7.5 were incubated
at 37 °C for 10 min. In another Eppendorf tube (B) 200 µg
of Met-INFα-2b prepared in 25 mM HEPES buffer pH 7.5
was added to make 400 µL reaction. From tube A, 80 µL
of solution was transferred into another Eppendorf tube
containing 10 µL of 10% TFA; then 20 µL of solution from
tube B was added and kept at –20 °C until analysis. To the
remaining solution A, all the solution B was added and
then 100 µL of the reaction mixture was taken at a time
at an interval of 10 min, quenched. Timewise change in
the HPLC elution peaks was monitored, and the product
formation and substrate consumption were calculated
(Arif et al., 2015).
2.7. Protein 3D modelling and validation
The Met-IFNα-2b structure was built using the I-TASSER
server (Lovell et al., 2002), which develops 3D models
from structure templates identified by LOMETS from
the PDB library. The templates of the highest significance
in the threading alignments were selected by I-TASSER.
Subsequently, the quality of the predicted model was
examined by RAMPAGE, a protein structure validation
server, which reveals the results in terms of phi, psi, and
cBeta deviations by generating a Ramachandran plot for the
protein built (Lovell et al., 2002).
2.8. Molecular docking and free energy calculation
3D structures of IFNα-2b with and without N-terminal
methionine and MAP were retrieved from the protein
structure database identified as 2KZ1 (Lowther et al., 1999),
1N6V (Chill et al., 2003), and 1C21 (Nudelman et al., 2010),
respectively. I-TASSER-made ‘IFNα-2b with methionine’
and ‘without methionine’ were structurally aligned by
PyMOL for structural similarity analysis. Later, both ligands
were docked against the receptor (IFNΑR2) using the Hex
docking server (Macindoe et al., 2010). Additionally, IFNα2b without methionine was also docked with MAP and the
DG (free energy change) of each docked protein–ligand
complex was recorded to analyze the complexes.
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3. Results
3.1. Production of recombinant E. coli methionine
aminopeptidase
Maximum expression of recombinant enzyme in the soluble
and functional form was obtained when the host bacterial
cells were induced overnight under 0.4 mM IPTG at 20
°C and 100 rpm. Enzyme was purified by anion exchange
chromatography; major enzyme fractions eluted from the
Q-Sepharose Column between 0.15 and 0.25 M NaCl were
analyzed on SDS-PAGE (Figure 1). The molecular weight
determined by MALDI-TOF was 29200.941 Da (Figure 2).
The purified enzyme has optimum pH 7.5 and maximum
activity was measured at 37 °C in the presence of 2 mM
cobalt ions.
3.2. Enzyme activity with different substrates
The specific activity of enzyme with methionyl-pnitroanilide was 1.64 µmol/min/mg. At time 0, the HPLC
profile indicated a single peak for the substrate elution.
After 5 min, half of the substrate was converted to the

Figure 1. SDS-PAGE photograph indicating the expressed and
purified E. coli methionine aminopeptidase. Lane M - Protein
Marker (Thermo Fisher catalogue No. SM 0671), Lane 1- pET21a
containing induced cells, Lane 2 - pET21a-MAP containing
induced cell lysate. Lane 3 - Purified enzyme.
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Figure 2. Molecular weight determination by MALDI-TOF analysis of purified
recombinant methionine aminopeptidase. X-axis indicates the protein MW in
Daltons and the Y-axis indicates the intensity of laser beam. The spectrum shows
[M + 1H] +1 ion peak at 29,200.941. Theoretical value of [M + 1H] +1 ion is
29,199.7084 Da.

product and after 10 min all the MGMM tetrapeptide was
converted into the product GMM (Figure 3). Looking at
the elution peak area of the substrate and assuming that
half of the substrate was consumed in 5 min, the specific
activity of the enzyme was calculated as 1.51 µmol of the
substrate consumed/min/mg of enzyme (Table 1).
3.3. Processing of human interferon α-2b
The HPLC profile of recombinant human interferon
α-2b showed three peaks representing three species, one
without N-terminal methionine having molecular weight
19,265 Da, the second acetyl-interferon α-2b without
N-terminal methionine but acetylated having molecular
weight 19,307 Da, and the third Met-interferon α-2b with
methionine having molecular weight 19,396 Da. For the
purified recombinant E. coli methionine aminopeptidase,
the HPLC profile indicating the progress of the reaction
was demonstrated after 0, 10, 20, 30, and 40 min (Figure
4), and the reaction was stopped after 36% of the substrate
was consumed (Supplementary Table ST1).
3.4. Protein 3-D modelling and validation
The I-TASSER-generated Met-IFNα-2b protein model
was visualized by PyMOL Molecular Graphics System,

Version 1.2r3pre (Figure 5). RAMPAGE, a protein
structure validation server, and the Ramachandran plot
collectively revealed that the template-based structure
of IFNα-2b built was quite stable (Supplementary Table
ST2; Supplementary Figure SF1). Despite having only one
amino acid difference in the primary structure, the MetINF and nonmet-INF have visible differences in their
secondary structures and 3-D arrangements.
3.5. Molecular docking and comparative analysis
Molecular docking of IFNAR2/INFα-2b without
methionine exhibited the lowest free energy change
(ΔG –784.53 kJ/mol), indicating higher binding affinity,
followed by IFNAR2/met-INFα-2b (ΔG –717.63 KJ/
mole) (Figure 6). The formation of INF-enzyme complex
was described. The interaction of amino acids with the
cobalt ions in the active site pocket was elaborated. The
free energy change for the ES-complex formation was
calculated as ΔG –683.07 kJ/mol) (Figure 7).
4. Discussion
Generally the recombinant proteins expressed in E.
coli represent the translation product comprising the
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Figure 3. Reverse phase HPLC analysis of the substrate MGMM
consumption in the reaction mixture containing 1.9 mM
substrate and 0.026 mg of E. coli methionine aminopeptidase
using C8 column. X-axis is the retention time in min and Y-axis
is absorbance at 220 nm.

amino acid sequence encoded by the gene. From time to
time, however, posttranslation modifications have been
observed that modulate the activity of most eukaryote
proteins (Mann and Jensen, 2003). One amongst these

is the removal of N-terminal methionine catalyzed
by methionine aminopeptidase and acetylation by
acetyltransferase (Liao et al., 2004). These enzymes are
found ubiquitously and show preference for the removal of
N-terminal methionine if the next residue in the sequence
has a small side chain (Xiao et al., 2004; Aksnes et al.,
2016). In the case of E. coli expression, the recombinant
protein is overexpressed; the native E. coli aminopeptidase
being produced in limited amount fails to process all of the
recombinant polypeptides. Hence, in the present study, in
vitro processing of interferon α-2b at the N-terminus was
the major part of the investigation. The in vitro removal
of N-terminal methionine from the recombinant proteins
is well established (Arfin et al., 1988; Mitra et al., 2006;
Arif et al., 2015, 2016). Our study was meant to report the
expression and purification of E. coli enzyme with emphasis
on the in silico insights into the ES-complex formation by
met-INFα-2b and MAP, the binding free energy change of
ES-complex formation. We also investigated the binding
free energy changes of INF molecules with and without
methionine at the N-terminus and their corresponding
receptor. The methionine aminopeptidase gene from E.
coli DH5 α was expressed in E. coli BL21 (DE3) RIL codon
plus cells. Gene expression in the bacterial culture was
induced by 0.4 mM IPTG after the onset of the log phase.
Induced bacterial culture was incubated overnight in a
shaking incubator adjusted to 20 °C and 100 rpm (BenBassat et al., 1987; Lowether et al., 2000). Recombinant
E. coli methionine aminopeptidase was purified by anion
exchange chromatography; it exhibited a molecular
weight of 29,200 Da on MALDI-TOF, which is nearest
to the theoretical molecular weight of enzyme without
N-terminal methionine as determined by ProtParam
(29,311.91 Da). Specific activity of enzyme was 1.64 U/mg
in the methionyl p-nitroanilide-based assay. It exhibited
1.51 U/mg specific activity with synthetic tetrapeptide
(MGMM) in an HPLC-based assay (Figure 3). Studies on
MAP have shown different specific activity when different
substrates were used (Vasina et al., 1996), indicating the
effect of substrate structure on enzyme activity (Lowther

Table 1. The amount of enzyme, activity and specific activity of methionine aminotransferase demonstrated by
using MGMM as substrate.
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Total concentration of substrate used in the assay

1.9 mM

1.9 µmol/mL

Concentration of substrate used in 66 µL reaction

(1.9 × 66) ÷ 1000

0.1254 µmol

Amount of substrate consumed in 5 min (half)

0.1254 µmol ÷ 2

0.0627 µmol

Amount of substrate consumed in 1 min

0.0627 ÷ 5

0.013 µmol

Amount of enzyme used in each reaction

(0.026 × 66) ÷ 200

0.0086 mg

Specific activity of the enzyme with MGMM

0.013 ÷ 0.0086

1.51 µmol/min/mg

ARIF et al. / Turk J Biol

Figure 4. Reverse phase HPLC using C8 analytical column analysis of E. coli methionine aminopeptidase
treated Met-Interferon α-2b. X-axis indicates the retention time in min and Y-axis represents absorbance at
220 nm.

et al., 1999; Xiao et al., 2010). Recombinant enzyme
successfully processed recombinant human interferon as
monitored by the HPLC-based assay system (Figure 4). A
3D model of INF was built by I-TASSER and validated by
the protein structure validation server RAMPAGE (Lovell
et al., 2002), which indicates the phi and psi deviations
via Ramachandran. The difference in amino terminal
methionine on the N-terminus resulted in detectable
changes in the secondary and tertiary structures of INF
with and without N-terminal as indicated by comparative
analysis (Figure 5). The structural difference indicated by
the comparative analysis makes the most of the recombinant
fraction (with N-terminal methionine) different from the
native (removed amino terminal methionine). We suggest
a possible immune response by the human body against
this structural difference between native and recombinant

interferon. The idea is also supported by the literature
(Mukovozov et al., 2008). The built structure was similar
to those reported in previous studies (Ya et al., 2003). Our
docking results showed that IFNAR2 is the natural protein
partner of IFNα-2b (without methionine) as their docking
complex exhibited ΔG –784.53 kJ/mol. The IFNAR2/metINFα2b complex exhibited a ΔG –717.63 kJ/mol, indicating
a comparatively low binding affinity of met-INFα-2b to the
corresponding receptor IFNAR2 (Figure 6). The results are
in correlation with the studies showing better response of
native interferon as compared to the recombinant (Karlberg
et al., 2010). The receptor for human interferon alpha
consists of two subunits, i.e. IFNAR1 and IFNAR2. The
subunit IFNAR2 has (nanomolar dissociation constant)
greater affinity to IFNs without the presence of IFNAR1
(Gull et al., 2013) and is considered the major ligand-
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Figure 5. A - 3-D model of IFN α-2b with methionine represented as cartoons, methionine is highlighted as blue sticks;
B - Superimposed IFN α-2b with methionine (red) and IFN-2b without methionine (green) (visualized by PyMol).

Figure 6. Docking complexes represented in surface view. A - IFNα-2b with methionine (green) and receptor IFNΑR2 (light
blue); B - IFNα -2b without methionine (red) and IFNΑR2 (light blue).

binding component; rationally it gains more attraction
in IFN docking studies. The NMR-based docking study
of IFNAR2/INFα-2b also revealed participation of the
N-terminus and A-helix of IFNα2 and the C-domain
of IFNAR2. Free energy change of MAP/met-IFNα-2b
complex (ES-complex) formation was ΔG –683.07 kJ/mol
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as determined by molecular docking studies. Active site
pocket interacting with cobalt ions is indicated clearly as
pink spheres (Figure 7). The role of active site amino acids
and cobalt ions has been described by previous reports
(Lowther et al., 1999; De Weerd et al., 2003). Here we
provide a structural elaboration of Asp97, Asp108, His171,

ARIF et al. / Turk J Biol

Figure 7. A - Methionine aminopeptidase (yellow) docked with template build IFNα-2b-Methionine (red); Cobalt Ions
(Pink spheres). B - Zoom-in view of MAP putative residues (Green sticks) binding with Cobalt ions (pink Spheres).

Glu204, and Glu235 side chains interacting with cobalt
ions. In summary, N-terminal methionine processing
of human interferon α-2b has importance to obtain a
single polypeptide species in the final product. Molecular
docking studies revealed dissimilarities in the 3-D
structure, putative receptor binding position, and binding
free energy change of recombinant INF2b with and
without N-terminal methionine. Based on these results, we

advocate a functional superiority of recombinant INFα-2b
without N-terminal methionine.
Acknowledgment
This article was funded by the Deanship of Scientific
Research (DSR) at King Abdulaziz University Jeddah.
The authors, therefore, acknowledge with thanks DSR for
technical and financial support.

References
Aksnes H, Drazic A, Arnesen MM (2016). First things first: vital
protein marks by n-terminal acetyltransferases. Trends
Biochem Sci 41: 746-760.
Allen WJ, Balius TE, Mukherjee S, Brozell SR, Moustakas DT, Lang
PT, Case DA, Kuntz ID, Rizzo RC (2015). DOCK 6: impact
of new features and current docking performance. J Comput
Chem 36: 1132-1156.
Arfin SM, Bradshaw RA (1988). Cotranslational processing and
protein turnover in eukaryotic cells. Biochem 27: 7979-7984.
Arif A, Gardner, QAA, Rashid N, Akhtar M (2015). Production of
human interferon alpha-2b in Escherichia coli and removal
of N-terminal methionine utilizing archaeal methionine
aminopeptidase. Biologia 70: 282-287.
Arif A, Rashid N, Aslam F, Mahmood N, Akhtar M (2016). Biased
expression, under the control of single promoter, of human
interferon α-2b and Escherichia coli methionine amino
peptidase genes in E. coli, irrespective of their distance from
the promoter. Pak J Pharm Sci 29: 375-379.

Ben-Bassat A, Bauer K, Chang SY, Myambo K, Boosman A, Chang S
(1987). Processing of the initiation methionine from proteins:
properties of the Escherichia coli methionine aminopeptidase
and its gene structure. J Bacteriol 169: 751-757.
Bingel-Erlenmeyer R, Kohler R, Kramer G, Sandikci A, Antolic S,
Maier T, Schaffitzel C, Wiedmann B, Bukau B, Ban N (2008). A
peptide deformylase-ribosome complex reveals mechanism of
nascent chain processing. Nature 452: 108-111.
Bradford MM (1976). A rapid and sensitive method for the
quantitation of microgram quantities of protein utilizing the
principle of protein-dye binding. Anal Biochem 72: 248-254.
Calcagno S1, Klein CD (2016). N-Terminal methionine processing
by the zinc-activated Plasmodium falciparum methionine
aminopeptidase 1b. Appl Microbiol Biotechnol 100: 70917102.
Cantu-Bustos J, Kevin ED, Villar CD, Vargas-Cortez T, MoronesRamirez JR, Balderas-Renteria I, Zarate X (2016). Recombinant
protein production data after expression in the bacterium
Escherichia coli. Data in Brief 7: 502-508.

247

ARIF et al. / Turk J Biol
Chen A, Sun Y, Zhang W, Peng F, Zhan C, Liu M, Yang Y, Bai Z (2016).
Downsizing a pullulanase to a small molecule with improved
soluble expression and secretion efficiency in Escherichia coli.
Microb Cell Fact 15: 9.
Chill JH, Quadt SR, Levy R, Schreiber G, Anglister J (2003). The
human type I interferon receptor: NMR structure reveals the
molecular basis of ligand binding. Structure 11: 791-802.
De Weerd NA, Samarajiwa SA, Hertzog PJ (2007). Type I interferon
receptors: biochemistry and biological functions. J Biol Chem
282: 20053-20057.
Dolores DNM, Ortiz A (2016). Enzyme replacement therapy for
Fabry disease. J Inborn Errors Metabol Screen 4: 1-7.
Elleuche S, Schäfers C, Blank S, Schröder C, Antranikian G
(2015). Exploration of extremophiles for high temperature
biotechnological processes. Curr Opin Microbiol 25: 113-119.
Giglione C, Boularot A, Meinnel T (2004). Protein N-terminal
methionine excision. Cell Mol Life Sci 61: 1455-1474.
Goh HC, Sobota RM, Ghadessy FJ, Nirantar S (2017). Going native:
complete removal of protein purification affinity tags by
simple modification of existing tags and proteases. Prot Exp
Purification 129: 18-24.
Gull I, Samra ZQ, Aslam MS (2013). Heterologous expression,
immunochemical and computational analysis of recombinant
human interferon alpha 2b. SpringerPlus 2: 264.

Lowther WT, Zhang Y, Sampson PB, Honek JF, Matthews BW (1999).
Insights into the mechanism of Escherichia coli methionine
aminopeptidase from the structural analysis of reaction
products and phosphorus-based transition-state analogues.
Biochem 38: 14810-14819.
Macindoe G, Mavridis L, Venkatraman V, Devignes MD, Ritchie
DW (2010). HexServer: an FFT-based protein-docking
server powered by graphics processors. Nucleic Acid Res 38:
W445-W449.
Mann M, Jensen ON (2003). Proteomic analysis of post-translational
modifications. Nat Biotechnol 2: 255-261.
Miljic D, Miljic P, Doknic M, Pekic S, Stojanovic M, Cvijovic G,
Micic D, Popovic V (2013). Growth hormone replacement
normalizes impaired fibrinolysis: new insights into endothelial
dysfunction in patients with hypopituitarism and growth
hormone deficiency, Growth Horm IGF Res 23: 243-248.
Mitra S, Dygas-Holz AM, Jiracek J, Zertova M, Zakova L,
Holz RC (2006). A new colorimetric assay for methionyl
aminopeptidases: examination of the binding of a new class of
pseudo peptide analogue inhibitors. Anal Biochem 357: 43-49.
Mukovozov I, Sabljic T, Hortelano G, Ofosu FA (2008). Factors
that contribute to the immmunogenicity of therapeutic
recombinant human proteins. Thromb Haemost 100: 874-882.

Helgren TR, Wangtrakuldee P, Staker BL, Hagen TJ (2016). Advances
in bacterial methionine aminopeptidase inhibition. Curr Top
Med Chem 16: 397-414.

Nudelman I, Akabayov SR, Schnur E, Biron Z, Levy R, Xu Y, Anglister
J (2010). Intermolecular interactions in a 44 kDa interferon receptor complex detected by asymmetric reverse-protonation
and two-dimensional NOESY. Biochem 49: 5117-5133.

Jia B, Jeon CO (2016). High-throughput recombinant protein
expression in Escherichia coli: status and future perspectives.
Open Biol 6: 160196.

Rider P, Carmi Y, Cohen I (2016). Biologics for targeting inflammatory
cytokines, clinical uses, and limitations. Int J Cell Biol Article
ID 9259646: 11.

Kanodia JS, Kim Y, Tomer R, Khan Z, Chung K, Storey JD, Lu H,
Keller PJ, Shvartsman SY (2011). A computational statistics
approach for estimating the spatial range of morphogen
gradients. Development 138: 4867-4874.

Seal BS (2013). Characterization of bacteriophages virulent for
Clostridium perfringens and identification of phage lytic
enzymes as alternatives to antibiotics for potential control of
the bacterium. Poult Sci 92: 526-533.

Karlberg H, Lindegren G, Mirazimi A (2010). Comparison of
antiviral activity of recombinant and natural interferons against
Crimean-Congo hemorrhagic fever virus. Open Virol J 4: 38.

Shepelkova G, Evstifeev V, Majorov K, Bocharova I, Apt A (2016).
Therapeutic effect of recombinant mutated interleukin 11 in
the mouse model of tuberculosis. J Infect Dis 214: 496-501.

Laemmli UK (1970) Cleavage of structural proteins during the
assembly of the head of bacteriophage T4. Nature 227: 680-685.

Tripathi NK (2016). Production and purification of recombinant
proteins from Escherichia coli. Chem BioEng Rev 3: 116-133.

Lagasse HA, Levin DD, Hengel H, Golding B, Sauna ZE (2017). Fcfusion drugs have C1q/FcγR binding and signaling properties
that can affect their immunogenicity. J Immunol 198: 129.13.

Urbano F, Acquafredda A, Aceto G, Penza R, Cavallo L (2012).
Unusual pediatric co-morbility: autoimmune thyroiditis and
cortico-resistant nephrotic syndrome in a 6-month-old Italian
patient. Ital J Pediatr 38: 57.

Liao YD, Jeng DJ, Wang CF, Wang SC, Chang ST (2004). Removal
of N-terminal methionine from recombinant proteins by
engineered E. coli methionine aminopeptidase. Protein Sci 13:
1802-1810.
Lovell SC, Davis IW, Arendall WB, de Bakker PIW, Word JM,
Prisant MG, Richardson JS, Richardson GC (2002). Structure
validation by Calpha geometry: phi, psi and Cbeta deviation.
Proteins: Structure, Function & Genetics 50: 437-450.
Lowether WT, Matthews BW (2000). Structure and function of the
methionine aminopeptidases. Biochim Biophys Acta 1477:
157-167.

248

Vairo F, Netto C, Dorneles A, Mittelstadt S, Wilke M, Doneda D,
Michelin K, Ribeiro CB, Quevedo A, Vieira T et al. (2013).
Enzyme replacement therapy in a patient with Gaucher disease
type III: a paradigmatic case showing severe adverse reactions
started a long time after the beginning of treatment. JIMD Rep
11: 1-6.
Vasina JA, Baneyx F (1996). Recombinant protein expression at low
temperatures under the transcriptional control of the major
Escherichia coli cold shock promoter cspA. Appl Environ
Microbiol 62: 1444-1447.

ARIF et al. / Turk J Biol
Venkatachalam CM, Jiang X, Oldfield T, Waldman M (2003).
LigandFit: a novel method for the shape-directed rapid
docking of ligands to protein active sites. J Mol Graph Model
21: 289-307.

Ya LJ, Cui YM, Chen LL, Gu M, Li J, Nan FJ, Ye QZ (2003). Mutations
at the S1 sites of methionine aminopeptidases from Escherichia
coli and Homo sapiens reveal the residues critical for substrate
specificity. Biochem Biophys Res Comm 307: 172.

Wingfield PT (2017). N-terminal methionine processing. Curr
Protoc Protein Sci 88: 6141-6143.

Yang J, Zhang Y (2015). I-TASSER server: new development for
protein structure and function predictions. Nucleic Acid Res
43: W174-W181.

Xiao Q, Zhang F, Nacev BA, Liu JO, Pei D (2010). Protein N-terminal
processing substrate specificity of Escherichia coli and human
methionine aminopeptidases. Biochem 49: 5588-5599.

Zhou Y, Guo XC, Yi T, Yoshimoto T, Pei D (2000). Two continuous
spectrophotometric assays for methionine aminopeptidase.
Analytic Biochem 280: 159-65.

249

ARIF et al. / Turk J Biol
Table ST1. Timewise change in the peak area and peak height of Met-interferon α-2b and interferon
α-2b due to reaction with E.coli methionine aminopeptidase.
0 min
Protein

Peak area

Peak height

% of Met-Ifn converted to Ifn

Ifn

0

0

0

Met-Ifn

24242

202

0

Protein

Peak area

Peak height

% of Met-Ifn converted to Ifn

Ifn

3675

58

Met-Ifn

20568

175

Protein

Peak area

Peak height

Ifn

2944

57

Met-Ifn

8828

110

10 min

15%

20 min
% of Met-Ifn converted to Ifn
25%

30 minutes
Protein

Peak area

Peak height

Ifn

4622

61

Met-Ifn

8403

95

Protein

Peak area

Peak height

Ifn

6848

90

Met-Ifn

12015

116

% of Met-Ifn converted to Ifn
35%

40 minutes
% of Met-Ifn converted to Ifn
36%

Table ST2. Quality evaluations of 3D protein model built by I-TASSER using various parameters
and software.
Protein

C-scorea

TM-scoreb*

RMSDc*

IDENd*

Cove*

IFN-2b

1.44

0.895

1.88 Å

0.970

0.970

Confidence (C) score for estimating the quality of predicted models (range –5 to 2).
Template modeling score (TM-score) measures the structural similarity between two structures
(TM-score > 0.5 indicates a model of correct topology and a TM-score < 0.17 means a random
similarity range 0 to 1).
c
Heavy atoms root-mean-square deviation (RMSD) with respect to the experimental structure.
d
IDEN is the percentage sequence identity in the structurally aligned region (range 0 to 1).
e
Cov represents the coverage of global structural alignment and is equal to the number of
structurally aligned residues divided by length of the query protein cluster (range 0 to 1).
*As compared to template ‘1itf ’
a

b

1
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Figure SF 1. The Ramachandran plot generated by the RAMPAGE server depicting the quality of the
built protein INF alpha 2b with methionine cap.
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